Bradykinin-potentiating peptides (BPPs -5a, 7a, 9a, 10c, 11e, and 12b) of Bothrops jararaca (Bj) were described as argininosuccinate synthase (AsS) activators, improving L-arginine availability. Agmatine and polyamines, which are L-arginine metabolism products, have neuroprotective properties. Here, we investigated the neuroprotective effects of low molecular mass fraction from Bj venom (LMMF) and two synthetic BPPs (BPP10c, < ENWPHPQIPP; BPP-12b, < EWGRPPGPPIPP) in the SH-SY5Y cell line against H 2 O 2 -induced oxidative stress. The neuroprotective effects against H 2 O 2 -induced were analyzed by reactive oxygen species (ROS -DCFH) production; lipid peroxidation (TBARS); intracellular GSH; AsS, iNOS, and NF-kB expressions; nitrite levels (Griess); mitochondrial membrane potential (TMRM); and antioxidant activity (DPPH). Analysis of variance followed by Tukey's post hoc test were calculated for statistical comparisons. Pre-treatment with both BPPs significantly reduced cell death induced by H 2 O 2 , but BPP-10c showed higher protective capacity than BPP-12b. LMMF pretreatment was unable to prevent the reduction of cell viability caused by H 2 O 2 . The neuroprotective mechanism of BPP-10c against oxidative stress was investigated. BPP-10c reduced ROS generation and lipid peroxidation in relation to cells treated only with H 2 O 2 . BBP-10c increased AsS expression and was not neuroprotective in the presence of MDLA, a specific inhibitor of AsS. BPP-10c reduced iNOS expression and nitrate levels but decreased NF-kB expression. Furthermore, BPP-10c protected the mitochondrial membrane against oxidation. Overall, we demonstrated for the first time neuroprotective mechanisms of BPPs against oxidative stress, opening new perspectives to the study and application of these peptides for the treatment of neurodegenerative diseases.
Introduction
Studies regarding the pathophysiological mechanisms of poisoning and the molecular characterization of toxins from Bothrops jararaca (Bj) snake venom have resulted in many scientific contributions of great relevance, such as the discovery of Bradykinin (Bk) and the first natural Angiotensin-converting enzyme (ACE) inhibitors, known Bradykininpotentiating peptides (BPPs) [1] . BPPs are proline-rich peptides described as antihypertensive molecules that inhibit hypotensive peptide (Bk) degradation and vasoconstrictor peptide (Angiotensin-II -Ang-II) formation [2] . BPPs are oligopeptides rich in proline that display bradykinin-potentiating activity, range from 5 to 14 amino acid residues, and display a common pyroglutamic acid (< E) residue at the Nterminal position, PXP motif, and a proline residue at the C-terminal position [3] . Besides controlling blood pressure, some components of the Renin-Angiotensin System (RAS) including ACE and Angiotensin receptors (ATR) also participate in neurodegenerative diseases, promoting neuroinflammation and increasing oxidative stress [4, 5] . Ang-II is the main RAS inflammatory molecule and can induce glial activation and the release of pro-inflammatory cytokines. ACE inhibitors or ATR blockers have neuroprotective properties and have been shown to reduce the release of inflammatory cytokines, up-regulate the expression of antioxidant enzymes, and reduce cognitive impairments in animal models of neurodegenerative diseases [5] [6] [7] [8] [9] [10] .
BPP-10c is a selective ACE C-domain inhibitor [2] and also kinetically modulates the argininosuccinate synthetase (AsS) activity in vitro and in vivo; the binding of BPP-10c to AsS enhances the affinity of the enzyme for ATP and citrulline [11] . Consequently, it induces nitric oxide (NO) production in endothelial cells and blood pressure reduction [12] [13] [14] . AsS catalyzes argininosuccinate formation through aspartate and citrulline conjugation. Once formed, argininosuccinate is cleaved by argininosuccinate lyase, giving rise to fumarate and L-arginine [15] . This amino acid participates in several metabolic pathways, including the production of neuroprotective molecules such as polyamines (spermine, spermidine, and putrescine) and agmatine [16] . Polyamines are responsible for synaptogenesis, axonogenesis, migration of neuronal cells, and regeneration of axons after trauma [17] . Spermidine pretreatment has been shown to attenuate 3-nitropropionic acid-induced alterations in motor coordination, oxidative stress, and neuroinflammatory markers in an animal model of Huntington disease [18] . Polyamines could prevent alterations in mitochondrial membrane permeability, regulating Ca 2+ concentrations and NOS activity [18, 19] .
Agmatine, another metabolite from L-arginine, is described as a neuroprotective agent since it reduced the loss of hippocampal neurons and the rate of cell death promoted by glutamate excess in ischemia models [20] . In animal models of Parkinson's disease (PD) and schizophrenia induced by reserpine, agmatine reduced oxidative stress and presented anti-dyskinesia effects [21] . It is reported that agmatine suppressed the iNOS expression and activity by inhibiting the nuclear transcription factor NF-κB, thereby decreasing the inflammatory process and cell death in culture [22] . In addition, agmatine promotes the dissociation of the transcription factor Nrf2 and its subsequent translocation to the nucleus, activating the transcription of genes responsible for antioxidant response [23, 24] . Furthermore, agmatine promotes neuroprotection by inhibiting the process of apoptosis induced by a tumor necrosis factor (TNF-α) [25] . Agmatine is also considered a neurotransmitter, producing a voltage-and concentration-dependent block of the NMDA receptor channel in hippocampal pyramidal neurons and antagonizing the excitatory action of the main postsynaptic neurotransmitters [26] . Pharmacologically, agmatine blocks some forms of hyperalgesia, increases the luteinizing hormone-releasing from the hypothalamus, reduces morphine tolerance, and is a neuroprotective compound with straightforward therapeutic potential [26] .
Recently, our group showed for the first time that low molecular mass fraction (LMMF) from Bj has neuroprotective activity in cultured hippocampal cells against H 2 O 2 -induced oxidative stress, reducing cell death and the expression of caspase-3 and caspase-8 [27] . In oxidative conditions, LMMF reduced the AsS and superoxide dismutase (SOD1) expressions. LMMFs contain several protein (< 10 kDa) and peptide components [28] . Peptide fraction analysis of Bj venoms by MALDI-TOFMS showed the presence of eleven BPPs (9a, 10b, 10c, 11a, 11d, 11e, 12b, 12c, 13a, 13b, 14a) [29] . While this fraction has demonstrated neuroprotective properties under particular experimental conditions, the neuroprotective mechanisms remain unknown. In this context, we purposed that the BPPs found in the LMMF could increase the AsS activity, improving L-arginine and consequently polyamines synthesis with neuroprotective properties. In the present study, we investigated the neuroprotective activity of BPP-10c, BPP-12b, and LMMF in H 2 O 2 -induced cytotoxicity in the human neuroblastoma cell line SH-SY5Y.
Experimental procedure

Chemical reagents and crude venom
All chemical reagents used in the present study were of analytical reagent grade (purity higher than 95%) and purchased from SigmaAldrich Corporation (USA). The crude venom (CV) lyophilized from Bj was supplied by the Herpetology Laboratory from the Butantan Institute (Sao Paulo, Brazil) and stored at −20°C until use.
LMMF and BPPs synthesis
LMMF was obtained as described by Querobino et al. [27] . Lyophilized CV (20 mg/mL) was solubilized in Tris-HCl (50 mM, pH 7.0) and filtered using a molecular cutoff membrane of 10 kDa (Amicon ® , Merck-Millipore, Hessen, Germany). BPP-10c (< ENWPHPQIPP), BPP12b (< EWGRPPGPPIPP), and the inverted sequence of BPP-10c [(inv) BPP-10c; PPIQPHPWNE] were purchased from FastBio (Ribeirão Preto, Brazil). The purity of the peptides was analyzed by high-performance liquid chromatography (HPLC) and was higher than 98%.
Cell culture
The human neuroblastoma cell line SH-SY5Y (CRL-2266) was obtained from ATCC (American Type Culture Collection, Manassas, VA, USA) and maintained in DMEM supplemented with 15% fetal bovine serum, penicillin/streptomycin (100 U/mL; 100 mg/mL), and 2 mM Lglutamine at 37°C in a humidified atmosphere containing 5% CO 2 /95% air.
Cell viability assay
Cells were seeded in 96-well plates (Nest Biotechnology, Rahway, USA) at 1.0 × 10 5 /well and treated with CV or LMMF (0.001, 0.01, 0.1, 1.0, and 10 μg/mL) or BPPs (0.1, 1, and 10 μM) for 3, 6, 12, 24, and 48 h. Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Briefly, after the different treatments, the medium was removed, and 50 μL of MTT (0.5 mg/mL) was added to each well. The plate was incubated for 1 h at 37°C. Then, the medium was removed, and 150 μL of dimethylsulfoxide (DMSO) was added to each well to dissolve the formazan crystals. After 15 min of homogenization, the cell viability was determined by absorbance of samples at 590 nm using Spectramax ® (Molecular Devices, CA, EUA). The optical density of the formazan obtained in the control cells was taken as 100% viability. Data were expressed as the mean ± standard deviation of viable cells percentage in relation to the control [30] .
Neuroprotection assay
Cells were placed on 96-well plates (Nest Biotechnology, Rahway, USA) at 1.0 × 10 5 /well, and the BPPs neuroprotective properties were evaluated in cells pretreated either with LMMF (0.1 μg/mL, LMMF group), BPP-10c (1 μM, 10c group), or BPP-12b (1 μM, 12b group). After 4 h, the oxidative stress was induced with H 2 O 2 (450 μM) for 20 h (LMMF + H 2 O 2; 10c + H 2 O 2 ;12b + H 2 O 2 ) [27, 31] . Captopril (30 μM), L-N Ω -Nitroarginine methyl ester (L-NAME group, 1 mM) and the inverted sequence of BPP-10c [(inv)BPP-10c group] were also tested in cells pretreated for 4 h; then, oxidative stress was induced with H 2 O 2 (450 μM) for 20 h. Afterwards, all groups were analyzed by MTT viability assay.
Protein extraction and western blot analyses
Cells were placed on 6 well plates (Nest Biotechnology, Rahway, USA) at 2.0 × 10 6 /well and were treated as described above for neuroprotective assays. At the end of the exposition periods, cells were washed twice with phosphate-buffered saline (PBS) cold, scraped off, and proteins were extracted with RIPA buffer containing protease inhibitors (1% Triton X-100, 0.5% Sodium deoxycholate, 0.3% SDS, 150 mM NaCl, 100 mM protease inhibitors, 100 mM PMSF, 50 mM TrisHCl, pH 7.4) for 15 min at 4°C. Lysates were then centrifuged at 21130 x g for 10 min at 4°C, and the supernatants were used as the total cell lysates. The protein content in the supernatants was quantified by the Bradford method [32] . Twenty micrograms of protein were separated on 12% sodium dodecyl sulfate (SDS)-polyacrylamide gels [33] and transferred to nitrocellulose membranes (Millipore, Billerica, MA). Each membrane was incubated for 2 h with 5% BSA in 0.1 M Tris buffered saline-0.1% Tween 20 (TBS-T) buffer (pH 7.4) to block nonspecific binding. Then, the immunostaining was performed with antiAsS (2.5 μg/mL -AV41336 -Sigma-Aldrich), anti-iNOS
anti-β-actin (1:4000-A1978-Sigma-Aldrich). After washing, the blots were incubated with appropriate secondary anti-rabbit HRP-conjugate (1:2000-111035003 -Jackson Immunoresearch) or anti-mouse (1:2000-115035003 -Jackson Immunoresearch, PA, EUA) for 2 h at room temperature. Each protein was detected by using a Lightning Chemiluminescence Reagent Plus ECL kit (ECL, Amersham, UK) for 1 min in a transilluminator detection system (Uvitec; Cambridge, UK). The band intensity was quantified by NIH ImageJ densitometric analysis.
AsS involvement in neuroprotection
Cells were seeded in 96-well plates (Nest Biotechnology, Rahway, USA) at 1.0 × 10 5 /well and treated with α-Methyl-DL-aspartic acid (MDLA, 1 mM, Sigma-Aldrich), an AsS specific inhibitor, for 1 h [34] . Then, BPP-10c (1 μM, MDLA + 10c group) was added for 4 h, and then H 2 O 2 was added (450 μM, MDLA +10c +H 2 O 2 group). The cell viability in all groups was analyzed by MTT assay.
Nitrite (NO) assay
NO production was assessed as nitrite (NO 2 ) concentration using modified Griess reagent (Sigma-Aldrich, St. Louis, MO). Cells were seeded in 6 well plates (Nest Biotechnology, Rahway, USA) at 2.0 × 10 6 /well. After treatments, 100 μL of supernatant was collected and mixed with an equal volume of modified Griess reagent (0.04 mg/ mL) followed by a 15-min incubation at room temperature. A standard curve was made with NaNO 2 concentrations ranging from 0.5 to 60 μM under the same conditions. The absorbance was determined with a microplate reader (Spactramax) at 540 nm.
ROS quantification
ROS generation was measured using 2′,7′ -dichlorodihydrofluorescein diacetate (H 2 DCF-DA, Sigma-Aldrich) staining. SH-SY5Y cells were plated at 0.71 × 10 5 cell/cm 2 . After the treatments, the medium was collected and centrifuged (9,9391 x g) for 5 min. Aliquots of 50 μL were separated and added with 150 μL of PBS in a 96-well dark plate (SPL Life Science -Gyeonggi-do, Korea). Five μL of H 2 DCF-DA (1 mM) was added into each well, and the plate was incubated for 1 h at 37°C. The fluorescence intensity was measured using Spectramax (Molecular Devices, CA, EUA) with its excitation at 480 nm and emission at 530 nm. The results of each experiment were reported as mean values from triplicate wells as arbitrary units [35] .
Mitochondrial membrane potential assay
The mitochondrial membrane potential (ΔYm) was evaluated using tetramethylrhodamine methyl ester perchlorate (TMRM, Thermofischer, MA, USA). Cells were placed on 96-well plates (Nest Biotechnology, Rahway, USA) at 1.0 × 10 5 /well. After the treatments, the culture medium was removed, and 1 μM of TMRM was added to the cells, followed by incubation at 37°C for 40 min. Then, cells were washed three times with PBS. The fluorescence was taken in the spectrofluorimeter (Spctramax, Molecular Devices, CA, EUA) at an excitation wavelength of 540 nm and emission wavelength of 570 nm according to the manufacturer's instructions.
Lipid peroxidation measurement
Cells were placed on 6 well plates (Nest Biotechnology, Rahway, USA) at 2.0 × 10 6 /well. After the treatments, cells were washed twice with PBS and homogenized at 4°C in 20 mM phosphate buffer (pH 7.4).
The protein content in the supernatants was quantified by the Bradford method [32] . The lipid peroxidation was determined by assessing the amount of thiobarbituric acid reactive substance (TBARS) in terms of malondialdehyde (MDA). Briefly, proteins were precipitated with trichloroacetic acid (10%), and then thiobarbituric acid (7.1%) was added. The solution was heated for 60 min in a boiling water bath. After cooling, the flocculent precipitate was removed by centrifugation at 18407×g for 5 min. The fluorescence of the supernatant was measured at an excitation wavelength of 515 nm and an emission wavelength of 532 nm against a blank that contained all of the reagents minus the cell homogenate. The results were expressed as nmol MDA formed per milligram of protein [36] .
Total glutathione assay
Intracellular GSH measurements were performed as described in the literature [37] . Cells were seeded in 6 well plates (Nest Biotechnology, Rahway, USA) at 2.0 × 10 6 /well. Briefly, cells were washed twice with PBS and scraped off at 4°C in 20 mM phosphate buffer (pH 7.4). Proteins were precipitated with metaphoric acid (0.2 M) and centrifuged at 7000 x g for 10 min at 4°C. The supernatant (50 μL) was transferred to a 96-well plate, and then an equal volume of GSH buffer was added (7.25 mM NaH 2 PO 4 , 92.75 mM Na 2 HPO 4 , 100 mM NaPO 4 , 5 mM EDTA, 0.05 mg/mL Ortho-phthaldialdehyde). The plate was incubated for 15 min in the dark, and the fluorescence was determined at the excitation (350 nm) and emission (420 nm) wavelengths of the microplate emitter (Spectramax ® ). A calibration curve was prepared with standard GSH (0.001-1 mM), and the concentrations were calculated as nmol GSH/mg protein.
Antioxidant activity by DPPH assay
Antioxidant activity w as determined by DPPH free radical assay, as described by Brand-Williams et al. [38] . BPP (1 μM; 14 μL) was added to a 96-well plate in triplicate followed by 250 μL of DPPH solution (20 mg/mL -Sigma-Aldrich). As a negative control, 40 μL of ultrapure water was used; rutine (100 and 1000 mg/mL -Sigma-Aldrich) was used as a positive control. The plate was incubated at room temperature (25°C) for 10 min, and the absorbance of the reaction was measured each 30 s for 10 min using Spectramax (Molecular Devices, CA, EUA) at 517 nm.
Statistical analyses
All data analyses were performed using GraphPad Prism 6.0 software (GraphPad Software, Inc., La Jolla, CA). Data are expressed as mean ± SD of three independent experiments (n = 3) in triplicate. The significance level of treatment effects was determined using a one-way or two-way analysis of variance (ANOVA) followed by Tukey's or Bonferroni multiple comparison tests, respectively, between groups. Values of p < 0.05 were considered to be statistically significant.
Results
Cell viability after treatment with either LMMF or CV and BPP-10c or BPP-12b
LMMF did not show cytotoxic activity in all experimental conditions tested (p > 0.05) compared to the control (Fig. 1A-E) . Lower concentrations of CV (0.001, 0.01, 0.1, and 1 μg/mL) were not cytotoxic during the experimental period, whereas CV at 10 μg/mL reduced the cell viability at all times tested (Fig. 1A-E) . BPP-10c and BPP-12b did not alter the cell viability in all concentrations and times tested (Fig. 1F-H) .
LMMF, BPP-10c, and BPP-12b neuroprotective activities
Initially, the H 2 O 2 cytotoxic effect was evaluated in the SH-SY5Y cell culture by MTT reduction. H 2 O 2 was cytotoxic at concentrations greater than 200 μM after 24 h of treatment, showing a dose-response effect ( Fig. 2A) . A 450-μM dose was chosen for subsequent studies. LMMF (0.1 μg/mL) pretreatment did not prevent the reduction of cell viability caused by H 2 O 2 (Fig. 2B) . On the other hand, BPP-10c showed better protective capacity than BPP-12b cell treatment (Fig. 2B ). Cells pretreated with (inv)BPP-10c did not present significant differences in relation to cells treated with 450 μM of H 2 O 2 . The protective properties against H 2 O 2 -induced cytotoxicity of L-NAME (1 mM) and the captopril (30 μM), iNOS, and ACE inhibitors, respectively, were also evaluated in our study. L-NAME pre-treatment prevented cell viability reduction, but captopril was not able to modify the toxicity caused by H 2 O 2 exposition.
Involvement of AsS and iNOS in BPP-10c-mediated neuroprotection
BPP-10c treatment significantly increased AsS expression when compared to untreated SH-SY5Y cells. AsS levels were also higher when cells were pre-incubated with BPP-10c and exposed to H 2 O 2 (Fig. 3A) . Moreover, BPP-10c significantly reduced iNOS expression compared to the control whereas this decreased iNOS expression was abolished when cells were exposed to H 2 O 2 after BPP-10c treatment (Fig. 3B) . When BPP-10c was added in a culture pretreated with MDLA (1 mM, a specific inhibitor of AsS), its neuroprotective effect of BPP-10c was not detected (Fig. 3C ). In addition, the nitrate levels in the culture media of cells exposed to H 2 O 2 , BPP-10c, and BPP-10c plus H 2 O 2 were significantly reduced compared with control cells (Fig. 3D). 3.4. Neuroprotective effect of BPP-10c on H 2 O 2 -induced oxidative stress markers and NF-κB expression H 2 O 2 significantly increased ROS and MDA levels and decreased mitochondrial membrane potential (ΔΨm), whereas BPP-10c did not modify these parameters (Fig. 4) . However, BPP-10c decreased ROS production and was able to restore control levels (Fig. 4A) ; it also abolished ΔΨm reduction (Fig. 4B ) and prevented lipid peroxidation (Fig. 4C ) in cells exposed to H 2 O 2 . In addition, cells exposed to H 2 O 2 increased GSH levels compared to the control group. In contrast, pretreatment with BPP-10c attenuated the rise in GSH levels elicited by H 2 O 2 (Fig. 4D) . The radical scavenging activity of BPP-10c was not able to sequester free radicals compared with the flavonoid rutine (positive control group) (Fig. 4E) . BPP-10c treatment reduced NF-κB expression (1 μM) pretreatments prevented loss of cell viability induced by H 2 O 2 (450 μM); captopril did not prevent the cell death. In addition, the (inv)10c group did not avoid cell death, demonstrating that the amino acid sequence is important to the observed neuroprotective activity of BPP-10c. Values are expressed as mean ± standard deviation from three independent experiments (n = 3) and analyzed by one-way ANOVA followed by Tukey's post-test. *p < 0.05 to differences among the control and experimental groups, # p < 0.05 when compared with the H 2 O 2 group. LMMF: Low molecular mass fraction; 10c: BPP10c; 12b: BPP-12b; inv(10c): inverted sequence of BPP-10c, L-NAME: L-N Ω -Nitroarginine methyl ester.
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Discussion
LMMF from Bj venom is composed of a large variety of BPPs, including 9a, 10b, 10c, 11a, 11d, 11e, 12b, 12c, 13a, 13b, and 14a [29] , which are functionally described as ACE inhibitors [1, 13, 14, 39, 40] . Despite their high amino acid sequence similarities, they display remarkable functional differences, including in different biological systems [12, 13, 34, [41] [42] [43] . In situ hybridization studies has revealed the presence of the BPPs mRNAs, including BPP-10c, in distinct regions of the Bj brain correlated with neuroendocrine functions, which include aldosterone secretion, excretion of sodium, and diuresis [44] . In addition, biodistribution studies of BPP-10c revealed the accumulation of this peptide in various mouse tissues, including the brain [45] .
Antihypertensive activity exerted by BPP-10c may involve actions on the central nervous system, including the effect might not depend of ACE inhibition and BK-B2 receptor activation [41] . In this study BPP10c induced free intracellular calcium concentration and released neurotransmitters in neuronal cells, which could explain its central cardiovascular effects [41] . In our study, a new property of BPP-10c is identified using H 2 O 2 -induced oxidative stress model in SH-SY5Y cell culture. BPP-10c, a peptide capable of positively modulating AsS activity, exhibited neuroprotective properties against H 2 O 2 -induced toxicity in SH-SY5Y cell cultures. BPP-10c increased AsS expression without modifying neither iNOS levels nor NO synthesis in an oxidative stress condition. We proposed BPP-10c improves the L-arginine synthesis and that its metabolites preferentially lead to agmatine formation with a neuroprotective property [22] [23] [24] 46] , which is related to reduction of lipid peroxidation, oxidative stress, and maintenance of Bj snake venom is composed of many proteins and bioactive peptides responsible for tissue injury and hemorrhage; among them, many are cytotoxic in different cell types [27, 47] . CV (10 μg/mL) reduced SH-SY5Y cell viability as expected, probably by presence of enzymatic compounds in crude venom [48] [49] [50] [51] [52] [53] . Nevertheless, LMMF, BPP-10c, and BPP-12b were not cytotoxic in SH-SY5Y cells in all of the concentrations tested.
ACE inhibitors are reported by improve neurodegenerative disorders such as dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, stroke, and diabetic neuropathy [6, 7, 9, 10, 54] . We recently reported that LMMF has neuroprotective property against oxidative damage in hippocampal primary culture cells, reducing apoptotic markers [27] . However, in the current study, LMMF containing a large variety of BPPs and captopril, a widely known ACE inhibitor, did not show protective capacity against H 2 O 2 -induced toxicity in SH-SY5Y cells. In addition, a previous study has suggested that the treatment of SH-SY5Y with captopril for 5 days reduces cell growth by decreasing thymidine incorporation into DNA [55] . These results indicate that ACE activity is possibly unrelated to neuroprotection against oxidative stress in these cells.
Neurodegeneration is a complex process that involves many molecular and cellular events, such as oxidative stress, mitochondrial dysfunction, protein misfolding, excitotoxicity, and inflammation [56] . Different neurodegenerative diseases models are described in the literature, but a common point between them is the presence of oxidative stress [57, 58] . The cellular stress model used in this work was based on the H 2 O 2 -induced oxidative stress [59, 60] . Here, H 2 O 2 promoted cell death in a dose-dependent manner, and we adopted the necessary concentration (450 μM of H 2 O 2 ) to reduce 70% cell viability, as reported in other studies [60, 61] .
A neuroprotective compound should be able to prevent neuronal loss and/or maintain its structure and function, reducing cell impairment and death [62] . The neuroprotective activity of BPP-10c was more efficient than BPP-12b, preserving cell viability against the H 2 O 2 -induced damage. It is very interesting that the BPP-10c effects are dependent on its primary molecular structure, since no neuroprotective property was found in cells treated with (inv)BPP-10c, which contains the inverted BPP-10c sequence. BPP-12b is the most susceptible to hydrolysis by proteolysis [63] and promotes a potent and long-lasting reduction of blood pressure in hypertensive animals, similar to promoted by BPP-10c; however, BPP-10c increases AsS activity and L-arginine availability more than BPP-12b [11, 14] . Again, we demonstrated that BPP-10c also significantly increased AsS expression in other cellular types (i.e., SH-SY5Y neuroblastoma cells). Polyamines (spermine, spermidine, and putrescine) and agmatine generated from L-arginine metabolism have neuroprotective activity [21] [22] [23] [24] 64] . Interestingly, our results showed that MDLA, an AsS enzyme-specific inhibitor, attenuated neuroprotective activity of BPP-10c against H 2 O 2 -induced toxicity in SH-SY5Y cells. Another relevant aspect is that L-arginine can also be metabolized to NO, whose neurotoxic effects include oxidative damage and activation of signaling cascades responsible for cell death [65] . In astroglioma C6 cells, BPP-10c increased NO synthesis without changing iNOS expression [34] . In contrast, in our study, BPP-10c reduced iNOS expression and was accompanied by decreased NO synthesis in SH-SY5Y cells. It has been widely reported that iNOS expression is controlled by many nuclear factors, mainly by NF-κB [66, 67] . We also showed that BPP-10c reduced NF-κΒ p65 expression, which is associated with iNOS. NO synthesis reduction indicates the presence of a preferred pathway for the metabolism of Larginine in SH-SY5Y cells, such as polyamine synthesis rather than NO synthesis.
Antioxidant molecules are capable of neutralizing free radicals by accepting or donating electrons to eliminate those that are mismatched [68], preventing ROS generation, oxidation of proteins and lipids, and acting to avoid the cell damage [69] . ROS opens specific pores in the mitochondrial membrane, activating the intrinsic apoptosis pathway [70] [71] [72] [73] . H 2 O 2 reduces mitochondrial membrane potential in SH-SY5Y cells [60, 74] . BPP-10c reduced ROS production and consequently attenuated the membrane potential changes and lipid peroxidation caused by H 2 O 2 exposition. This indicates that it can also promote neuroprotection by avoiding mitochondrial changes and plasma membrane fluidity. In addition, this peptide does not have the ability to directly act as a reactive-species scavenger as demonstrated in the DPPH assay. Therefore, the neuroprotective effect of BPP-10c is not related to its ability to accept unpaired electrons and thus reduce the amount of ROS in the medium. However, BPP-10c can promote neuroprotection by altering the synthesis of antioxidant molecules such as polyamines, avoiding changes in mitochondrial membrane permeability and lipid peroxidation, according to the literature [75, 76] .
Endogenous GSH is the main naturally-occurring antioxidant in the brain and is used to evaluate the non-enzymatic antioxidant capacity of a tissue to prevent damage associated with free radical processes [77] . H9c2 cells submitted to H 2 O 2 -induced oxidative stress for 24 and 48 h increased GSH production due to a mechanism of tolerance adapted to the induced stress [78] . Our results in SH-SY5Y cells exposed to H 2 O 2 also showed an increase in the GSH levels, which was partially attenuated by BPP-10c. Then, this peptide could reduce oxidative stress and thus decrease the adaptive responses to H 2 O 2 exposition .
Overall, this is the first study on the neuroprotective effects of two different BPPs using a H 2 O 2 -induced oxidative stress model in SH-SY5Y cell cultures. BPP-10c, an AsS activator, has neuroprotective activity against H 2 O 2 -induced oxidative stress in SH-SY5Y cells. H 2 O 2 is an ROS inducer that can stimulate the excessive production of ROS; it may target mitochondria, open the permeation transition pores, and decrease mitochondrial membrane potentials, lipid peroxidation, and cell death [58, 59, 79, 80] . BPP-10c reduces ROS generation and consequently oxidative stress markers. In addition, BPP-10c increases AsS expression and improves the L-arginine synthesis, and its metabolism could preferentially lead to agmatine formation, which has been widely reported to have neuroprotective activity [20, 21, 23, 24, 76, 81, 82] . Consequently, BPP-10c is related to decreased lipid peroxidation and oxidative stress as well as the maintenance of mitochondrial membrane potential. This study offers new perspectives for the elucidation of possible mechanisms involved in the neuroprotective property by BPP10c and thereby provides new insight into the biological features of BPPs.
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